Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Verastem Inc (NQ: VSTM )

0.4498 +0.0298 (+7.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 616,603
Open 0.4100
Bid (Size) 0.4500 (1)
Ask (Size) 0.4700 (8)
Prev. Close 0.4200
Today's Range 0.4150 - 0.4500
52wk Range 0.2895 - 2.130
Shares Outstanding 200,677,979
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Verastem Oncology Initiative, Let’s Talk About LGSOC, Calls Attention to Rare Form of Ovarian Cancer
From Verastem Oncology
Via Business Wire
Verastem Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress
From Verastem Oncology
Via Business Wire

Performance

YTD
+7.35%
+7.35%
1 Month
-7.75%
-7.75%
3 Month
+36.30%
+36.30%
6 Month
-51.23%
-51.23%
1 Year
-65.92%
-65.92%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Verastem Oncology Outlines Key 2023 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib as a Backbone of Therapy for RAS Pathway-Driven Cancers
From Verastem Oncology
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Verastem Oncology Announces Up to $60 Million Private Placement Offering of Series B Convertible Preferred Stock
From Verastem Oncology
Via Business Wire
Verastem Oncology Announces Positive Data and Regulatory Update from Planned Interim Analysis of Registration-Directed Phase 2 RAMP-201 Trial of Avutometinib and Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
From Verastem Oncology
Via Business Wire
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Verastem Oncology
Via Business Wire
Verastem Oncology Appoints Rob Gagnon to Board of Directors
From Verastem Oncology
Via Business Wire
Cigna To Rally 15%? Plus Needham Slashes PT On This Stock By 40%
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Verastem Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
From Verastem Oncology
Via Business Wire
10 Best Medical Stocks Under $5
Via Talk Markets
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Verastem Oncology Appoints Anil Kapur to Board of Directors
From Verastem Oncology
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Verastem Oncology
Via Business Wire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday
Via Benzinga
S&P 500 Rises 100 Points; Nasdaq Up 3%
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Why AeroClean Technologies Shares Are Trading Higher By Around 38%, Here Are 58 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nasdaq Surges 350 Points; Crude Oil Rises Sharply
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.